High-density expression of CD95 on B cells and underrepresentation of the B-1 cell subset in human lupus

Journal of Autoimmunity

Volumn 11, Issue 5, 1998, Pages 449-455

  Huck, Sylvie ^a   Jamin, Christophe ^b   Youinou, Pierre ^b   Zouali, Moncef ^a  

^a INSTITUT PASTEUR   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

Author keywords

Apoptosis; B cells; B 1 cells; CD5; CD95; Human autoantibodies; SLE

Indexed keywords

CD5 ANTIGEN; FAS ANTIGEN;

ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; APOPTOSIS; B LYMPHOCYTE ACTIVATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; LUPUS ERYTHEMATOSUS; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL;

EID: 0032191323     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1998.0226     Document Type: Conference Paper

References (53)

1. 1. Goodnow C.C., Cyster J.G., Hartley S.B., Bell S.E., Cooke M.P., Healy J.I., Akkaraju S., Rathmell J.C., Pogue S.L., Shokat K.P. 1995. Self-tolerance checkpoints in B lymphocyte development. Adv. Immunol. 59: 279-368
2. 2. Huck S., Zouali M. 1996. DNA methylation: a potential pathway to abnormal autoreactive lupus B cells. Clin. Immunol. Immunpathol. 80: 1-8
3. 3. Zouali M., Kalsi J., Isenberg D. 1993. Autoimmune diseases - at the molecular level. Immunol. Today 14: 473-476
4. 4. Bhat N.M., Kantor A.B., Bieber M.M., Stall A.M., Herzenberg L.A., Teng N.N. 1992. The ontogeny and functional characteristics of human B-1 (CD5+ B) cells. Int. Immunol. 4: 243-252
5. 5. Nisitani S., Murakami M., Akamizu T., Okino T., Ohmori K., Mori T., Imamura M., Honjo T. 1997. Preferential Localization of Human Cd5(+) B Cells in the Peritoneal Cavity. Scand. J. Immunol. 46: 541-545
6. 6. Brezinschek H.P., Foster S.J., Brezinschek R.I., Dorner T., Domiati-Saad R., Lipsky P.E. 1997. Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells. J. Clin. Invest. 99: 2488-2501
7. 7. Schettino E.W., Chai S.K., Kasaian M.T., Schroeder Jr H.W., Casali P 1997. VHDJH gene sequences and antigen reactivity of monoclonal antibodies produced by human B-1 cells: evidence for somatic selection. J. Immunol. 158: 2477-2489
8. 8. Jamin C., Le Corre R., Pers J.O., Dueymes M., Lydyard P.M., Youinou P. 1997. Modulation of CD72 by ligation of B cell receptor complex molecules on CD5+ B cells. Int. Immunol. 9: 1001-1009
9. 9. Reth M., Wienands J. 1997. Initiation and processing of signals from the B cell antigen receptor. Annu. Rev. Immunol. 15: 453-479
10. 10. Rickert R.C., Rajewsky K., Roes J. 1995. Impairment of T cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376: 352-355
11. 11. Pani G., Kozlowski M., Cambier J.C., Mills G.B., Siminovitch K.A. 1995. Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signalling [see comments]. J. Exp. Med. 181: 2077-2084
12. 12. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., Nagata S 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317
13. 13. Zhou T., Edwards C.K.R., Yang P., Wang Z., Bluethmann H., Mountz J.D. 1996. Greatly accelerated lymphadenopathy and autoimmune disease in Ipr mice lacking tumor necrosis factor receptor I. J. Immunol 156: 2661-2665
14. 14. Peng S., Moslehi J., Robert M., Craft J. 1998. Perforin protects against autoimmunity in lupus-prone mice. J. Immunol. 160: 652-660
15. 15. Rothstein T.L., Wang J.K., Panka D.J., Foote L.C., Wang Z., Stanger B., Cui H., Ju S.T., Marshak-Rothstein A. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374: 163-165
16. + T cells. Nature 376: 181-184
17. 17. Scott D.W., Grdina T., Shi Y 1996. T cells commit suicide, but B cells are murdered. J. Immunol. 156: 2352-2356
18. 18. Garrone P., Neidhardt E.M., Garcia E., Galibert L., van Kooten C., Banchereau J. 1995. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med. 182: 1265-1273
19. 19. Schattner E.J., Elkon K.B., Yoo D.H., Tumang J., Krammer P.H., Crow M.K., Friedman S.M. 1995. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med. 182: 1557-1565
20. 20. Martinez-Valdez H., Guret C., de Bouteiller O., Fugier I., Banchereau J., Liu Y.J. 1996. Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2. J. Exp. Med. 183: 971-977
21. 21. Mysler E., Bini P., Drappa J., Ramos P., Friedman S.M., Krammer P.H., Elkon K.B. 1994. The apoptosis-1/Fas protein in human systemic lupus erythematosus. J. Clin. Invest. 93: 1029-1034
22. 22. Ohsako S., Hara M., Harigai M., Fukasawa C., Kashiwazaki S. 1994. Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes. Clin. Immunol. Immunpathol. 73: 109-114
23. 23. Amasaki Y., Kobayashi S., Takeda T., Ogura N., Jodo S., Nakabayashi T., Tsutsumi A., Fujisaku A., Koike T. 1995. Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia. Clin. Exp. Immunol. 99: 245-250
24. 24. Emlen W., Niebur J., Kadera R. 1994. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 152: 3685-3692
25. 25. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., Schaller J.G., Talal N., Winchester R.J. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277
26. 26. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H. 1992. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 35: 630-640
27. 27. Zouali M., Theze J. 1991. Probing VH gene-family utilization in human peripheral B cells by in situ hybridization. J. Immunol. 146: 2855-2864
28. 28. Murakami M., Honjo T. 1995. B-1 cells and autoimmunity. Ann. New York Acad. Scie. 764: 402-409
29. 29. Jamin C., Lamour A., Pennec Y.L., Hirn M., Le Goff P., Youinou P. 1993. Expression of CD5 and CD72 on T and B cell subsets in rheumatoid arthritis and Sjogren's syndrome. Clin. Exp. Immunol 92: 245-250
30. 30. Jamin C., Le Corre R., Lydyard P.M., Youinou P. 1996. Anti-CD5 extends the proliferative response of human CD5+ B cells activated with anti-IgM and interleukin-2. Eur. J. Immunol. 26: 57-62
31. 31. Rothstein T.L., Kolber D.L., Murphy T.P., Cohen D.P. 1991. Induction of phorbol ester responsiveness in conventional B cells after activation via surface Ig. J. Immunol. 147: 3728-3735
32. 32. Cong Y.Z., Rabin E., Wortis H.H. 1991. Treatment of murine CD5-B cells with anti-Ig, but not LPS, induces surface CD5: two B cell activation pathways. Int. Immunol. 3: 467-476
33. 33. Werner-Favre C., Vischer T.L., Wohlwend D., Zubler R.H. 1989. Cell surface antigen CD5 is a marker for activated human B cells. Eur. J. Immunol. 19: 1209-1213
34. 34. Kawamura M., Wheeler C.J., Notkins A.L., Bich-Thuy L.T. 1994. Modulation of the expression of CD5 antigen on the surface of human peripheral B lymphocytes. Cell. Immunol. 159: 61-76
35. 35. Kazbay K., Osterland C.K. 1990. The frequency of Leu 1+B cells in autoantibody positive and negative autoimmune diseases and in neonatal cord blood. Clin. Exp. Rheumatol. 8: 231-235
36. + B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis. J. Rheumatol. 17: 833-835
37. 37. Plater-Zyberk C., Maini R.N., Lam K., Kennedy T.D., Janossy G. 1985. A rheumatoid arthritis B cell subset expresses a phenotype similar to that in chronic lymphocytic leukemia. Arthritis Rheum. 28: 971-976
38. 38. Dauphinee M., Tovar Z., Talal N. 1988. B cells expressing CD5 are increased in Sjögren's syndrome. Arthritis Rheum. 31: 642-647
39. 39. Casali P., Burastero S.E., Balow J.E., Notkins A.L. 1989. High-affinity antibodies to ssDNA are produced by CD-B cells in systemic lupus erythematosus patients. J. Immunol. 143: 3476-3483
40. 40. Suzuki N., Sakane T. 1989. Induction of excessive B cell proliferation and differentiation by an in vitro stimulus in culture in human systemic lupus erythematosus. J. Clin. Invest. 83: 937-944
41. - B cells of patients with systemic lupus erythematosus. J. Clin. Invest. 85: 238-247
42. 42. Miyawaki T., Uehara T., Nibu R., Tsuji T., Yachie A., Yonehara S., Taniguchi N. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149: 3753-3758
43. 43. Daniel P.T., Krammer P.H. 1994. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. J. Immunol. 152: 5624-5632
44. 44. Hirose S., Yan K., Abe M., Jiang Y., Hamano Y., Tsurui H., Shirai T. 1997. Precursor B cells for autoantibody production in genomically Fas-intact autoimmune disease are not subject to Fas-mediated immune elimination. Proc. Nat. Acad. Sci. USA 94: 9291-9295
45. + thymocytes by the anti-Fas antibody. J. Exp. Med 181: 485-491
46. 46. Cheng J., Zhou T., Liu C., Shapiro J.P., Brauer M.J., Kiefer M.C., Barr P.J., Mountz J.D. 1994. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263: 1759-1762
47. 47. Goel N., Ulrich D.T., St. Clair E.W., Fleming J.A., Lynch D.H., Seldin M.F. 1995. Lack of correlation between serum soluble Fas/APO-1 levels and autoimmune disease. Arthritis Rheum. 38: 1738-1743
48. 48. Knipping E., Krammer P.H., Onel K.B., Lehman T.J., Mysler E., Elkon K.B. 1995. Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis. Arthritis Rheum. 38: 1735-1737
49. 49. Jodo S., Kobayashi S., Kayagaki N., Ogura N., Feng Y., Amasaki Y., Fujisaku A., Azuma M., Yagita H., Okumura K., Koike T. 1997. Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases. Clin. Exp. Immunol. 107: 89-95
50. 50. Tokano Y., Miyake S., Kayagaki N., Nozawa K., Morimoto S., Azuma M., Yagita H., Takasaki Y., Okumura K., Hashimoto H. 1996. Soluble Fas molecule in the serum of patients with systemic lupus erythematosus. J. Clin. Immunol. 16: 261-265
51. 51. Mandik L., Nguyen K.A., Erikson J. 1995. Fas receptor expression on B-lineage cells. Eur. J. Immunol. 25: 3148-3154
52. 52. Bikah G., Carey J., Ciallella J.R., Tarakhovsky A., Bondada S. 1996. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 274: 1906-1909
53. 53. Masuda K., Wang J., Watanabe T. 1997. Reduced susceptibility to Fas-mediated apoptosis in B-1 cells. Eur. J. Immunol. 27: 449-455